Second-round tests begin on StrataGraft burn treatment developed in Madison

By Judy Newman, Wisconsin State Journal

StrataGraft is human cell-based skin tissue to treat burn woundsA second round of studies has begun on a skin tissue product developed by a Madison company, designed to treat patients with serious burns.

The first patient has been enrolled in a Phase 2 study of StrataGraft, the skin tissue developed by Madison-based Stratatech, now part of Mallinckrodt, a global pharmaceutical company.

 The study is expected to follow 20 patients to evaluate the success of StrataGraft in healing their wounds over a three-month period. The study is expected to be completed by late 2018, Mallinckrodt said. Read more …
Comments are closed.
Facebook IconYouTube IconTwitter IconVisit Our LinkedIn Profile